GC
KURA icon

Guggenheim Capital’s Kura Oncology KURA Stock Holding History

Guggenheim Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
+14,670
New +$126K ﹤0.01% 1566
2022
Q4 		– Sell
-21,770
Closed -$297K – 1952
2022
Q3 		$297K Sell
21,770
-1,200
-5% -$18.5K ﹤0.01% 1661
2022
Q2 		$421K Sell
22,970
-1,701
-7% -$24.5K ﹤0.01% 1646
2022
Q1 		$397K Buy
24,671
+914
+4% +$13.2K ﹤0.01% 1765
2021
Q4 		$333K Buy
23,757
+348
+1% +$5.64K ﹤0.01% 1829
2021
Q3 		$438K Sell
23,409
-543
-2% -$10.2K ﹤0.01% 1796
2021
Q2 		$499K Buy
23,952
+1,096
+5% +$27.2K ﹤0.01% 1829
2021
Q1 		$646K Buy
22,856
+10,900
+91% +$345K ﹤0.01% 1598
2020
Q4 		$390K Buy
+11,956
New +$420K ﹤0.01% 1740

Other funds holding KURA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return